Hartford Healthcare HLS Fund Class IB (HBGHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
13.34
-0.16 (-1.19%)
May 9, 2025, 4:00 PM EDT
-11.83% (1Y)
| Fund Assets | 350.11M |
| Expense Ratio | 1.18% |
| Min. Investment | $0.00 |
| Turnover | n/a |
| Dividend (ttm) | 0.11 |
| Dividend Yield | 0.83% |
| Dividend Growth | -54.38% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 13.50 |
| YTD Return | -7.04% |
| 1-Year Return | -11.23% |
| 5-Year Return | 15.13% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | 0.72 |
| Holdings | 106 |
| Inception Date | n/a |
About HBGHX
HBGHX is a mutual fund that trades on the NASDAQ stock exchange in the United States.
Category Health
Stock Exchange NASDAQ
Ticker Symbol HBGHX
Share Class Ib
Index S&P Composite 1500 Health Care TR
Performance
HBGHX had a total return of -11.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 20.24%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| HIAHX | Ia | 0.93% |
Top 10 Holdings
48.02% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.94% |
| UnitedHealth Group Incorporated | UNH | 9.97% |
| Boston Scientific Corporation | BSX | 4.70% |
| Merck & Co., Inc. | MRK | 3.90% |
| Intuitive Surgical, Inc. | ISRG | 3.38% |
| Vertex Pharmaceuticals Incorporated | VRTX | 2.92% |
| Thermo Fisher Scientific Inc. | TMO | 2.75% |
| Johnson & Johnson | JNJ | 2.54% |
| Cencora, Inc. | COR | 2.50% |
| AbbVie Inc. | ABBV | 2.42% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Aug 23, 2024 | $0.11309 | Aug 23, 2024 |
| Aug 25, 2023 | $0.24792 | Aug 25, 2023 |
| Aug 26, 2022 | $4.64694 | Aug 26, 2022 |
| Aug 27, 2021 | $2.6796 | Aug 27, 2021 |
| Aug 27, 2020 | $4.68939 | Aug 27, 2020 |
| Aug 27, 2019 | $3.22597 | Aug 27, 2019 |